502 related articles for article (PubMed ID: 14702150)
1. Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis.
Saito M; Nakagawa M; Kaseda S; Matsuzaki T; Jonosono M; Eiraku N; Kubota R; Takenouchi N; Nagai M; Furukawa Y; Usuku K; Izumo S; Osame M
J Infect Dis; 2004 Jan; 189(1):29-40. PubMed ID: 14702150
[TBL] [Abstract][Full Text] [Related]
2. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.
Nagai M; Kubota R; Greten TF; Schneck JP; Leist TP; Jacobson S
J Infect Dis; 2001 Jan; 183(2):197-205. PubMed ID: 11120926
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Saito M; Nose H; Usuku K; Sabouri AH; Matsuzaki T; Izumo S; Arimura K; Osame M
J Neurol Sci; 2006 Jul; 246(1-2):37-43. PubMed ID: 16545396
[TBL] [Abstract][Full Text] [Related]
4. Th1/Th2 balance and HTLV-I proviral load in HAM/TSP patients treated with interferon-alpha.
Feng J; Misu T; Fujihara K; Misawa N; Koyanagi Y; Shiga Y; Takeda A; Sato S; Takase S; Kohnosu T; Saito H; Itoyama Y
J Neuroimmunol; 2004 Jun; 151(1-2):189-94. PubMed ID: 15145617
[TBL] [Abstract][Full Text] [Related]
5. Different cytokine production in tax-expressing cells between patients with human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis and asymptomatic HTLV-I carriers.
Furukawa Y; Saito M; Matsumoto W; Usuku K; Tanaka Y; Izumo S; Osame M
J Infect Dis; 2003 Apr; 187(7):1116-25. PubMed ID: 12660926
[TBL] [Abstract][Full Text] [Related]
6. Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis.
Vine AM; Witkover AD; Lloyd AL; Jeffery KJ; Siddiqui A; Marshall SE; Bunce M; Eiraku N; Izumo S; Usuku K; Osame M; Bangham CR
J Infect Dis; 2002 Oct; 186(7):932-9. PubMed ID: 12232833
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
[TBL] [Abstract][Full Text] [Related]
8. Human T lymphotropic virus type I (HTLV-I) proviral load in cerebrospinal fluid: a new criterion for the diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis?
Lezin A; Olindo S; Oliere S; Varrin-Doyer M; Marlin R; Cabre P; Smadja D; Cesaire R
J Infect Dis; 2005 Jun; 191(11):1830-4. PubMed ID: 15871115
[TBL] [Abstract][Full Text] [Related]
9. Temporal dynamics of human T-lymphotropic virus type I tax mRNA and proviral DNA load in peripheral blood mononuclear cells of human T-lymphotropic virus type I-associated myelopathy patients.
Ramirez E; Cartier L; Torres M; Barria M
J Med Virol; 2007 Jun; 79(6):782-90. PubMed ID: 17457906
[TBL] [Abstract][Full Text] [Related]
10. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M
J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801
[TBL] [Abstract][Full Text] [Related]
11. Disulfide-mediated apoptosis of human T-lymphotrophc virus type-I (HTLV-I)-infected cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Nishiura Y; Nakamura T; Fukushima N; Nakamura H; Ida H; Aramaki T; Eguchi K
Antivir Ther; 2009; 14(4):533-42. PubMed ID: 19578238
[TBL] [Abstract][Full Text] [Related]
12. Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-Tac.
Lehky TJ; Levin MC; Kubota R; Bamford RN; Flerlage AN; Soldan SS; Leist TP; Xavier A; White JD; Brown M; Fleisher TA; Top LE; Light S; McFarland HF; Waldmann TA; Jacobson S
Ann Neurol; 1998 Dec; 44(6):942-7. PubMed ID: 9851439
[TBL] [Abstract][Full Text] [Related]
13. Human T lymphotropic virus type 1 (HTLV-1) proviral load in asymptomatic carriers, HTLV-1-associated myelopathy/tropical spastic paraparesis, and other neurological abnormalities associated with HTLV-1 infection.
Silva MT; Harab RC; Leite AC; Schor D; Araújo A; Andrada-Serpa MJ
Clin Infect Dis; 2007 Mar; 44(5):689-92. PubMed ID: 17278060
[TBL] [Abstract][Full Text] [Related]
14. Interferon-beta1a therapy in human T-lymphotropic virus type I-associated neurologic disease.
Oh U; Yamano Y; Mora CA; Ohayon J; Bagnato F; Butman JA; Dambrosia J; Leist TP; McFarland H; Jacobson S
Ann Neurol; 2005 Apr; 57(4):526-34. PubMed ID: 15786444
[TBL] [Abstract][Full Text] [Related]
15. Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy.
Goon PK; Biancardi A; Fast N; Igakura T; Hanon E; Mosley AJ; Asquith B; Gould KG; Marshall S; Taylor GP; Bangham CR
J Infect Dis; 2004 Jun; 189(12):2294-8. PubMed ID: 15181578
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I.
Puccioni-Sohler M; Yamano Y; Rios M; Carvalho SM; Vasconcelos CC; Papais-Alvarenga R; Jacobson S
Neurology; 2007 Jan; 68(3):206-13. PubMed ID: 17224575
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism in the interleukin-10 promoter affects both provirus load and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
Sabouri AH; Saito M; Lloyd AL; Vine AM; Witkover AW; Furukawa Y; Izumo S; Arimura K; Marshall SE; Usuku K; Bangham CR; Osame M
J Infect Dis; 2004 Oct; 190(7):1279-85. PubMed ID: 15346339
[TBL] [Abstract][Full Text] [Related]
18. [Immunopathogenesis and treatment of the myelopathy associated to the HTLV-I virus].
Carod-Artal FJ
Rev Neurol; 2009 Feb 1-15; 48(3):147-55. PubMed ID: 19206063
[TBL] [Abstract][Full Text] [Related]
19. The impact of interferon-alpha treatment on clinical and immunovirological aspects of HTLV-1-associated myelopathy in northeast of Iran.
Rafatpanah H; Rezaee A; Etemadi MM; Hosseini RF; Khorram B; Afsahr L; Taylor G; Mokhber N; Mahmoudi M; Abbaszadegan MR; Foroghipor M; Hashemi P; Amiri A; Tehrani M; Azarpazhooh A; Azarpazhooh MR
J Neuroimmunol; 2012 Sep; 250(1-2):87-93. PubMed ID: 22727800
[TBL] [Abstract][Full Text] [Related]
20. The elevated interferon gamma production is an important immunological marker in HAM/TSP pathogenesis.
Montanheiro PA; Penalva de Oliveira AC; Smid J; Fukumori LM; Olah I; da S Duarte AJ; Casseb J
Scand J Immunol; 2009 Oct; 70(4):403-7. PubMed ID: 19751276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
